Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Aradigm

- PMLiVE

Infex doses first patients in Pseudomonas aeruginosa phase 1 study

Pa is a leading cause of non-cystic fibrosis bronchiectasis exacerbations

- PMLiVE

NICE recommends Grifols’ Tavlesse for chronic immune thrombocytopenia

Patients with chronic ITP may live with an increased risk of severe bleeding events

- PMLiVE

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

Further evidence is required to warrant approval according to the US regulator

- PMLiVE

Haemophilia Society launches UK awareness drive

Charity tackles poor understanding of bleeding disorder

Novartis building

Novartis offloads diagnostics unit to Grifols for $1.7bn

Part of strategy to focus on more profitable businesses

Bayer launches late-stage lung condition trial for ciprofloxacin

Study involves the use of Novartis’ T-326 inhaler

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links